Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rod Jackson

Showing results (81-90 of 194) with videos related to

Pageof 20
Sort By:
Heart, Lung & Circulation|January 17, 2021
Trends in Ischaemic Heart Disease in Australia, 2001-2015: A Comparison of Urban and Rural PopulationsEng Joo Tan, Andrew Hayen, Philip Clarke, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|February 25, 2009
Modelling the potential impact of population-wide and targeted high-risk blood pressure-lowering strategies on cardiovascular disease in ChinaXueying Qin, Rod Jackson, Roger Marshall, et al.
Australian and New Zealand Journal of Public Health|February 23, 2008
Can the incidence and prevalence of coronary heart disease be determined from routinely collected national data? Population-based estimates for New Zealand in 2001--03Martin Tobias, Wing Cheuk Chan, Craig Wright, et al.
Clinical Epidemiology|February 3, 2018
Cardiovascular medication changes over 5 years in a national data linkage study: implications for risk prediction modelsSuneela Mehta, Rod Jackson, Sue Wells, et al.
Internal Medicine Journal|May 25, 2020
Increases in early discharge following acute coronary syndrome hospitalisations and associated clinical outcomes in New Zealand between 2006 and 2015: ANZACS-QI-43 studyTom Kai Ming Wang, Corina Grey, Yannan Jiang, et al.
BMJ Open Respiratory Research|January 26, 2021
Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?Lianne Parkin, Sheila Williams, David Barson, et al.
International Journal of Epidemiology|December 15, 2021
Predicting cardiovascular risk from national administrative databases using a combined survival analysis and deep learning approachSebastiano Barbieri, Suneela Mehta, Billy Wu, et al.
Lancet (London, England)|February 1, 2005
Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular riskRod Jackson, Carlene M M Lawes, Derrick A Bennett, et al.
The New Zealand Medical Journal|April 25, 2006
Cardiovascular risk factors and their associations with alcohol consumption: are there differences between Maori and non-Maori in Aotearoa (New Zealand)?Dale Bramley, Joanna Broad, Rod Jackson, et al.
The New Zealand Medical Journal|December 17, 2008
The burden of modifiable cardiovascular risk factors in the coronary care unit by age, ethnicity, and socioeconomic status--PREDICT CVD-9Andrew J Kerr, Andrew McLachlan, Sue Furness, et al.
Pageof 20

Showing results (81-90 of 194) with videos related to

Sort By:
Pageof 20
Heart, Lung & Circulation|January 17, 2021
Trends in Ischaemic Heart Disease in Australia, 2001-2015: A Comparison of Urban and Rural PopulationsEng Joo Tan, Andrew Hayen, Philip Clarke, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|February 25, 2009
Modelling the potential impact of population-wide and targeted high-risk blood pressure-lowering strategies on cardiovascular disease in ChinaXueying Qin, Rod Jackson, Roger Marshall, et al.
Australian and New Zealand Journal of Public Health|February 23, 2008
Can the incidence and prevalence of coronary heart disease be determined from routinely collected national data? Population-based estimates for New Zealand in 2001--03Martin Tobias, Wing Cheuk Chan, Craig Wright, et al.
Clinical Epidemiology|February 3, 2018
Cardiovascular medication changes over 5 years in a national data linkage study: implications for risk prediction modelsSuneela Mehta, Rod Jackson, Sue Wells, et al.
Internal Medicine Journal|May 25, 2020
Increases in early discharge following acute coronary syndrome hospitalisations and associated clinical outcomes in New Zealand between 2006 and 2015: ANZACS-QI-43 studyTom Kai Ming Wang, Corina Grey, Yannan Jiang, et al.
BMJ Open Respiratory Research|January 26, 2021
Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?Lianne Parkin, Sheila Williams, David Barson, et al.
International Journal of Epidemiology|December 15, 2021
Predicting cardiovascular risk from national administrative databases using a combined survival analysis and deep learning approachSebastiano Barbieri, Suneela Mehta, Billy Wu, et al.
Lancet (London, England)|February 1, 2005
Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular riskRod Jackson, Carlene M M Lawes, Derrick A Bennett, et al.
The New Zealand Medical Journal|April 25, 2006
Cardiovascular risk factors and their associations with alcohol consumption: are there differences between Maori and non-Maori in Aotearoa (New Zealand)?Dale Bramley, Joanna Broad, Rod Jackson, et al.
The New Zealand Medical Journal|December 17, 2008
The burden of modifiable cardiovascular risk factors in the coronary care unit by age, ethnicity, and socioeconomic status--PREDICT CVD-9Andrew J Kerr, Andrew McLachlan, Sue Furness, et al.
Pageof 20